Citigroup
PRAX icon

Citigroup’s Praxis Precision Medicines PRAX Stock Holding History

Citigroup’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$10.9M Buy
37,428
+13,829
+59% +$4.58M ﹤0.01% 1560
2026
Q2 		$7.9M Buy
23,599
+17,953
+318% +$5.68M ﹤0.01% 1779
2026
Q1 		$1.82M Buy
5,646
+60
+1% +$18.6K ﹤0.01% 2721
2025
Q4 		$1.65M Buy
5,586
+2,779
+99% +$518K ﹤0.01% 2785
2025
Q3 		$149K Sell
2,807
-9,059
-76% -$439K ﹤0.01% 4117
2025
Q2 		$499K Sell
11,866
-33,766
-74% -$1.29M ﹤0.01% 3629
2025
Q1 		$1.73M Sell
45,632
-49,415
-52% -$3.09M ﹤0.01% 2829
2024
Q4 		$7.31M Buy
95,047
+11,697
+14% +$846K ﹤0.01% 1623
2024
Q3 		$4.8M Buy
83,350
+75,739
+995% +$4.09M ﹤0.01% 1884
2024
Q2 		$315K Sell
7,611
-7,507
-50% -$355K ﹤0.01% 3661
2024
Q1 		$922K Sell
15,118
-8,406
-36% -$377K ﹤0.01% 3093
2023
Q4 		$524K Buy
23,524
+17,983
+325% +$324K ﹤0.01% 3376
2023
Q3 		$142K Buy
5,541
+5,529
+46,075% +$105K ﹤0.01% 3809
2023
Q2 		$214 Sell
12
-107
-90% -$1.64K ﹤0.01% 5427
2023
Q1 		$1.45K Sell
119
-18
-13% -$760 ﹤0.01% 5127
2022
Q4 		$4.89K Sell
137
-495
-78% -$15.4K ﹤0.01% 5035
2022
Q3 		$22K Sell
632
-15,606
-96% -$778K ﹤0.01% 4715
2022
Q2 		$597K Buy
16,238
+14,219
+704% +$1.52M ﹤0.01% 3077
2022
Q1 		$309K Sell
2,019
-3,359
-62% -$690K ﹤0.01% 3828
2021
Q4 		$1.59M Buy
5,378
+2,837
+112% +$832K ﹤0.01% 2806
2021
Q3 		$705K Buy
2,541
+81
+3% +$22K ﹤0.01% 3366
2021
Q2 		$674K Sell
2,460
-652
-21% -$233K ﹤0.01% 3496
2021
Q1 		$1.53M Buy
3,112
+2,966
+2,032% +$2.11M ﹤0.01% 2676
2020
Q4 		$120K Buy
+146
New +$85.2K ﹤0.01% 5395

Other funds holding PRAX

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
SEB Asset Management
SEB Asset Management Stockholm $27B AUM
CenterBook Partners
CenterBook Partners Greenwich, Connecticut $2.18B AUM 12.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Moody Aldrich Partners
Moody Aldrich Partners Marblehead, Massachusetts $523M AUM 75.24% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
Kornitzer Capital Management
Kornitzer Capital Management Shawnee Mission, Kansas $4.8B AUM 30.14% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Citigroup's PRAX Position: Q3 2026 in Review

Citigroup increased its Praxis Precision Medicines (PRAX) stake by 59% in Q3 2026, buying an estimated $4.58M and bringing the position to 37,428 shares worth $10.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1560.

Citigroup first reported a position in PRAX in Q4 2020 and has held it in 24 quarters since. 86 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.

  • Citigroup held 37,428 shares of Praxis Precision Medicines worth $10.9M as of Q3 2026.
  • Citigroup bought 13,829 Praxis Precision Medicines shares in Q3 2026, an estimated $4.58M.
  • Praxis Precision Medicines made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #1560 holding.
  • Citigroup first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 24 quarters since.
  • 86 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.